References
- Felson DT, Anderson JJ, Meenan RF. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis: results of two meta-analyses. Arthritis Rheum 1990; 33: 1449–61
- Getzsche PC, Pedenphant J, Olesen M, Halberg P. Meta-analysis of second-line antirheumatic drugs: sample size bias and uncertain benefit. J Clin Epidemiol 1992; 45: 587–94
- Felson DT, Anderson JJ. Critique of meta-analysis of second-line antirheumatic drugs [comment to the editors]. J Clin Epidemiol 1993; 46: 315–19
- Gøtzsche PC, Pødenphant J, Olesen M, Halberg P. Critique of meta-analysis of second-line antirheumatic drugs [comment to the editors]. J Clin Epidemiol 1993; 46: 319–21
- Iannuzzi L, Dawson N, Zein N, Kushner I. Does drug therapy slow radiographic deterioration in rheumatoid arthritis?. N Engl J Med 1983; 309: 1023–8
- Dickersin K, Min YI, Meinert CL. Factors influencing publication of research results: follow-up of applications submitted to two institutional review boards. JAMA 1992; 263: 374–8
- Arnett FC, Edsworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The 1987 revised American Rheumatism Association criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
- Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137–45
- Canadian Hydroxychloroquine Study Group. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 1991; 324: 150–4
- The Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA 1994; 272: 1926–31
- Williams JW, Holleman DR, Samsa GP, Simel DL. Randomized controlled trial of 3 vs 10 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis. JAMA 1995; 273: 1015–21
- Hawley DJ, Wolfe F. Are the results of controlled clinical trials and observational studies of second line therapy in rheumatoid arthritis valid and generalizable as measures of rheumatoid arthritis outcome: analysis of 122 studies. J. Rheumatol 1991; 18: 1008–14
- Karlowski TR, Chalmers TC, Frenkel LD, Kapikian AZ, Ixwis TL, Lynch JM. Ascorbic acid for the common cold. A prophylactic and therapeutic trial. JAMA 1975; 231: 1038–42
- Gøtzsche PC. Meta-analysis of NSAIDs: contribution of drugs, doses, trial designs, and meta-analytic techniques. Scand J. Rheumatol 1993; 22: 255–60
- Gøtzsche PC. Sensitivity of effect variables in rheumatoid arthritis: a meta-analysis of 130 placebo controlled NSAID trials. J Clin Epidemiol 1990; 43: 1313–8
- Hansen TM, Keiding S, Lauritzen SL, Manthorpe R, Serensen SF, Wiik A. Clinical assessment of disease activity in rheumatoid arthritis. Scand J Rheumatol 1979; 8: 101–5